Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

Bcl-2 is the best characterized inhibitor of apoptosis, although the molecular basis of this action is not fully understood. Using a protein interaction cloning procedure, we identified a human gene designated as bis (mapped to chromosome 10q25) that encoded a novel Bcl-2-interacting protein. Bis pr...

Full description

Saved in:
Bibliographic Details
Published inOncogene Vol. 18; no. 46; pp. 6183 - 6190
Main Authors LEE, J.-H, TAKAHASHI, T, YASUHARA, N, INAZAWA, J, KAMADA, S, TSUJIMOTO, Y
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing 04.11.1999
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bcl-2 is the best characterized inhibitor of apoptosis, although the molecular basis of this action is not fully understood. Using a protein interaction cloning procedure, we identified a human gene designated as bis (mapped to chromosome 10q25) that encoded a novel Bcl-2-interacting protein. Bis protein showed no significant homology with Bcl-2 family proteins and had no prominent functional motif. Co-immunoprecipitation analysis confirmed that Bis interacted with Bcl-2 in vivo. DNA transfection experiments indicated that Bis itself exerted only weak anti-apoptotic activity, but was synergistic with Bcl-2 in preventing Bax-induced and Fas-mediated apoptosis. These results suggest that Bis is a novel modulator of cellular anti-apoptotic activity that functions through its interaction with Bcl-2.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0950-9232
1476-5594
DOI:10.1038/sj.onc.1203043